Asked by: Baroness Linforth (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government how much of the £1.5 billion Estates Safety Fund funding announced on 9 September will be allocated towards implementing the conclusion in the Module 3 report from the UK Covid-19 Inquiry that "in the short term, the use of HEPA filters should be prioritised within healthcare across the UK".
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Estates Safety Fund schemes were selected by the National Health Service working with trusts and integrated care boards to prioritise the most urgent operational and safety risks, including ventilation requirements, and the schemes that will make the greatest difference to patients and staff.
No data is held on the proportion of the funding that will be directed towards the use of high-efficiency particulate air filters.
Asked by: Baroness Linforth (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to make Nuvaxovid available (1) on the NHS, and (2) privately, before the arrival of a new SARS-Cov-2 variant.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The procurement of COVID-19 vaccinations is based on the policy decisions made by my Rt Hon. Friend, the Secretary of State for Health and Social Care. These are informed by scientific advice from the Joint Committee on Vaccination and Immunisation. The Department cannot advise which brand of vaccine will form part of any future COVID-19 vaccination campaign.
The availability and purchasing of vaccines provided through the private market is a matter for suppliers and those offering private vaccination services directly. The Department is unable to advise which vaccine suppliers will be in stock with private vaccination services.